Controlled Substances

March 16, 2025 | Controlled Substances, Drug Courts, Fact Sheets, Harm Reduction, Peer Support and Recoery Services, Public Health, Public Safety, Recovery, Treatments

In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) details how opioid settlement proceeds are being disbursed to state and local governments, how those governments are choosing to spend those funds, and the obstacles that can prevent these funds from helping those who have been affected by the opioid epidemic....

March 5, 2025 | Controlled Substances, Fact Sheets, Fentanyl, Harm Reduction, Public Safety, Synthetic Drugs

In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) provides an overview of the sudden increase in the presence of BTMPS in the illicit drug supply and its rapid proliferation across the country, which has left drug policy experts and harm reduction specialists puzzled as to why it is in the supply and how it will affect the individuals consuming it....

January 30, 2025 | Controlled Substances, First Responders, Legal & Legislative Research, Naloxone, Opioid Antagonists, Opioid Antagonists, Opioids, Overdose Reversal Agent, Public Health, Public Safety, Substance Misuse

In an effort to save lives, states have implemented laws to make it easier for first responders and the general public to obtain overdose reversal agents, such as naloxone. Additionally, to encourage people to assist an individual who is or may be suffering an overdose, the majority of states also enacted laws which protect laypeople who administer overdose reversal agents, in good faith, in an emergency from civil and/or criminal liability. The Legislative Analysis and Public Policy Association (LAPPA) undertook an extensive research project to determine the current status of overdose reversal agent access laws throughout the United States, including the District of Columbia and all U.S. territories. As of January 2025, all 50 states and the District of Columbia have some form of an overdose reversal agent access law....

January 6, 2025 | Controlled Substances, Insurance, Model Laws, Public Health, Recovery, Substance Misuse, Treatments

The Mental Health and Substance Use Disorder Parity Act aims to empower effective enforcement of mental health and substance use disorder (SUD) parity standards at the state level. This model legislation requires: (1) health benefit plans to provide mental health and SUD benefits on terms no more restrictive than those for medical/surgical benefits; and (2) health insurers to demonstrate compliance with the Mental Health Parity and Addiction Equity Act for all state-regulated health benefit plans subject to the parameters of this legislation. The overarching purpose of this Act is to save lives and improve health and quality of life by expanding access to mental health and SUD treatment....

December 3, 2024 | Controlled Substances, Model Laws, Peer Support and Recoery Services, Public Health, Recovery, Substance Misuse, Workforce Development

Drafted in collaboration with the O’Neill Institute for National and Global Health Law at the Georgetown University Law Center, the purpose of the Model Building the Substance Use Disorder Workforce of the Future Act is to address the current and projected shortage of professions for the substance use disorder workforce, including psychiatrists, psychologists, physicians who are certified in addiction medicine, addiction counselors, social workers, nursing professionals, peer support professionals, and others. This legislation guides states in adopting a strategy that supports and advances immediate, intermediate, and long-term measures to build and sustain an SUD workforce....

November 5, 2024 | Controlled Substances, Medication Assisted Treatment (MAT), Opioids, Recovery, Reports & Studies, Treatments

The Heller School for Social Policy and Management at Brandeis University and the Legislative Analysis and Public Policy Association, together published a report that includes a comprehensive review of the laws and regulations that apply to methadone for opioid use disorder (OUD) to determine which laws and regulations would need to be amended in order to support pharmacy-based methadone treatment for OUD. This analysis (1) includes a discussion of the agencies involved in governing methadone for OUD treatment; (2) explains the provision in federal Controlled Substances Act that creates the regulatory scheme for methadone treatment; (3) describes DEA regulations governing Narcotic Treatment Programs; and (4) summarizes the general types of state laws and regulations that place additional restrictions on methadone for OUD treatment....

October 7, 2024 | Controlled Substances, Fact Sheets, Fentanyl, Novel Psychoactive Substances, Opioids, Substance Misuse

In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) discusses the emergence of  "tusi," which is also known as pink cocaine. Tusi is a group of psychedelic drugs common amongst clubgoers, dyed pink, that actually rarely contains cocaine. While tusi itself is not controlled under the Controlled Substances Act, its individual components like ketamine and fentanyl often are, and because users rarely know what is in the particular mix they are ingesting, they cannot anticipate the side effects....

September 24, 2024 | Controlled Substances, Criminal Justice, Harm Reduction, Law Enforcement, Opioids, Prescription Drugs, Public Health, Public Safety, Recovery, Substance Misuse, Toolkits

The Legislative Analysis and Public Policy Association (LAPPA), in partnership with the Institute for Intergovernmental Relations, developed several resources related to overdose fatality review (OFR), including a complete summary of state OFR laws, a guide on how OFR teams can obtain information from the Indian Health Service, and a guide on how OFR teams can obtain information from the Veterans Health Administration....